Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1350636-82-6
2. Bc-3781 Acetate
3. Acetic Acid;[(1s,2r,3s,4s,6r,7r,8r,14r)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[(1r,2r,4r)-4-amino-2-hydroxycyclohexyl]sulfanylacetate
4. Bc-3781.ac
5. Lefamulinacetate
6. Xenleta (tn)
7. Lefamulin Acetate (xenleta)
8. Chembl3545309
9. Dtxsid801027897
10. S3496
11. At18250
12. D11632
13. Q27279882
| Molecular Weight | 567.8 g/mol |
|---|---|
| Molecular Formula | C30H49NO7S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 567.32297408 g/mol |
| Monoisotopic Mass | 567.32297408 g/mol |
| Topological Polar Surface Area | 172 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 882 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Xenleta is indicated for the treatment of community-acquired pneumonia (CAP) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of CAP or when these have failed.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
J01XX
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Lefamulin Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lefamulin Acetate, including repackagers and relabelers. The FDA regulates Lefamulin Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lefamulin Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lefamulin Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lefamulin Acetate supplier is an individual or a company that provides Lefamulin Acetate active pharmaceutical ingredient (API) or Lefamulin Acetate finished formulations upon request. The Lefamulin Acetate suppliers may include Lefamulin Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Lefamulin Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Lefamulin Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lefamulin Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lefamulin Acetate GMP manufacturer or Lefamulin Acetate GMP API supplier for your needs.
A Lefamulin Acetate CoA (Certificate of Analysis) is a formal document that attests to Lefamulin Acetate's compliance with Lefamulin Acetate specifications and serves as a tool for batch-level quality control.
Lefamulin Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Lefamulin Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lefamulin Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Lefamulin Acetate EP), Lefamulin Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lefamulin Acetate USP).
LOOKING FOR A SUPPLIER?
